Movatterモバイル変換


[0]ホーム

URL:


Jump to content
WikipediaThe Free Encyclopedia
Search

Sazetidine A

From Wikipedia, the free encyclopedia
Pharmaceutical drug
Pharmaceutical compound
Sazetidine A
Identifiers
  • 6-[5-[(2S)-2-Azetidinylmethoxy]-3-pyridinyl]-5-hexyn-1-ol
CAS Number
PubChemCID
ChemSpider
UNII
CompTox Dashboard(EPA)
Chemical and physical data
FormulaC15H20N2O2
Molar mass260.337 g·mol−1
3D model (JSmol)
  • OCCCCC#Cc1cc(cnc1)OCC2CCN2
  • InChI=1S/C15H20N2O2/c18-8-4-2-1-3-5-13-9-15(11-16-10-13)19-12-14-6-7-17-14/h9-11,14,17-18H,1-2,4,6-8,12H2/t14-/m0/s1
  • Key:WONBUILDJNKYCB-AWEZNQCLSA-N
  (verify)

Sazetidine A (AMOP-H-OH) is a drug which acts as a subtype selectivepartial agonist atα4β2 neuralnicotinic acetylcholine receptors, acting as an agonist at (α4)2(β2)3 pentamers, but as an antagonist at (α4)3(β2)2 pentamers.[1][2] It has potentanalgesic effects in animal studies comparable to those ofepibatidine, but with less toxicity,[3] and also hasantidepressant action.[4]

References

[edit]
  1. ^Xiao Y, Fan H, Musachio JL, Wei ZL, Chellappan SK, Kozikowski AP, Kellar KJ (October 2006). "Sazetidine-A, a novel ligand that desensitizes alpha4beta2 nicotinic acetylcholine receptors without activating them".Molecular Pharmacology.70 (4):1454–60.doi:10.1124/mol.106.027318.PMID 16857741.S2CID 6599272.
  2. ^Zwart R, Carbone AL, Moroni M, Bermudez I, Mogg AJ, Folly EA, et al. (June 2008). "Sazetidine-A is a potent and selective agonist at native and recombinant alpha 4 beta 2 nicotinic acetylcholine receptors".Molecular Pharmacology.73 (6):1838–43.doi:10.1124/mol.108.045104.PMID 18367540.S2CID 24632914.
  3. ^Cucchiaro G, Xiao Y, Gonzalez-Sulser A, Kellar KJ (September 2008)."Analgesic effects of Sazetidine-A, a new nicotinic cholinergic drug".Anesthesiology.109 (3):512–9.doi:10.1097/ALN.0b013e3181834490.PMID 18719450.S2CID 22185882.
  4. ^Kozikowski AP, Eaton JB, Bajjuri KM, Chellappan SK, Chen Y, Karadi S, et al. (August 2009)."Chemistry and pharmacology of nicotinic ligands based on 6-[5-(azetidin-2-ylmethoxy)pyridin-3-yl]hex-5-yn-1-ol (AMOP-H-OH) for possible use in depression".ChemMedChem.4 (8):1279–91.doi:10.1002/cmdc.200900079.PMC 2955514.PMID 19569163.
Adamantanes
Adenosine antagonists
Alkylamines
Ampakines
Arylcyclohexylamines
Benzazepines
Cathinones
Cholinergics
Convulsants
Eugeroics
Oxazolines
Phenethylamines
Phenylmorpholines
Piperazines
Piperidines
Pyrrolidines
Racetams
Tropanes
Tryptamines
Others
Opioids
Opiates/opium
Semisynthetic
Synthetic
Paracetamol-type
NSAIDs
Propionates
Oxicams
Acetates
COX-2 inhibitors
Fenamates
Salicylates
Pyrazolones
Others
Cannabinoids
Ion channel
modulators
Calcium blockers
Sodium blockers
Potassium openers
Myorelaxants
Others
SSRIsTooltip Selective serotonin reuptake inhibitors
SNRIsTooltip Serotonin–norepinephrine reuptake inhibitors
NRIsTooltip Norepinephrine reuptake inhibitors
NDRIsTooltip Norepinephrine–dopamine reuptake inhibitors
NaSSAsTooltip Noradrenergic and specific serotonergic antidepressants
SARIsTooltip Serotonin antagonist and reuptake inhibitors
SMSTooltip Serotonin modulator and stimulators
Others
TCAsTooltip Tricyclic antidepressants
TeCAsTooltip Tetracyclic antidepressants
Others
Non-selective
MAOATooltip Monoamine oxidase A-selective
MAOBTooltip Monoamine oxidase B-selective
Miscellaneous
nAChRsTooltip Nicotinic acetylcholine receptors
Agonists
(andPAMsTooltip positive allosteric modulators)
Antagonists
(andNAMsTooltip negative allosteric modulators)
Precursors
(andprodrugs)
Retrieved from "https://en.wikipedia.org/w/index.php?title=Sazetidine_A&oldid=1270871868"
Categories:
Hidden categories:

[8]ページ先頭

©2009-2025 Movatter.jp